Page 1 | Search Results | Anesthesiology | American Society of Anesthesiologists

1-6 of 6

Sort by

Sort Order Select

Articles

Factor XII Deficiency and Cardiopulmonary Bypass : Use of a Novel Modification of the Activated Clotting Time to Monitor Anticoagulation

Mark A. Gerhardt, MD, PhD, Charles S. Greenberg, MD, Thomas F. Slaughter, MD, Mark Stafford Smith, MD, CM, FRCPC

Anesthesiology. October 1997: 87(4):990–992

https://doi.org/10.1097/00000542-199710000-00038

Published: October 1997

View article

Articles

Heparin-associated Thrombocytopenia and Thrombosis: Implications for Perioperative Management

Thomas F. Slaughter, MD, Charles S. Greenberg, MD

Anesthesiology. September 1997: 87(3):667–675

https://doi.org/10.1097/00000542-199709000-00029

Published: September 1997

View article

Articles

Practice Guidelines and Treatment of Patients with von Willebrand's Disease

Thomas F. Slaughter, MD, Charles S. Greenberg, MD

Anesthesiology. August 1996: 85(2):441–442

https://doi.org/10.1097/00000542-199608000-00042

Published: August 1996

View article

Articles

Characterization of Prothrombin Activation during Cardiac Surgery by Hemostatic Molecular Markers

Thomas F. Slaughter, M.D., Todd H. LeBleu, M.D., James M. Douglas, M.D., John B. Leslie, M.D., Judith K. Parker, B.S., Charles S. Greenberg, M.D.

Anesthesiology. March 1994: 80(3):520–526

https://doi.org/10.1097/00000542-199403000-00007

Published: March 1994

View article

Articles

Management of a Patient with Type IIC von Willebrand's Disease during Coronary Artery Bypass Graft Surgery

Thomas F. Slaughter, M.D., Elinor A. Mody, M.D., H. Newland Oldham, M.D., J. G. Reves, M.D., Christopher M. O'Connor, M.D., Judith K. Parker, B.S., Charles S. Greenberg, M.D.

Anesthesiology. January 1993: 78(1):195–197

https://doi.org/10.1097/00000542-199301000-00027

Published: January 1993

View article

Articles

“Heparin-free” Cardiopulmonary Bypass: First Reported Use of Heparinoid (Org 10172) to Provide Anticoagulation For Cardiopulmonary Bypass

Dennis C. Doherty, D.O., Thomas L. Ortel, M.D., Ph.D., Norbert de Bruijn, M.D., Charles S. Greenberg, M.D., Peter Van Trigt, M.D.

Anesthesiology. September 1990: 73(3):562–565

https://doi.org/10.1097/00000542-199009000-00034

Published: September 1990

View article

NARROW

Factor XII Deficiency and Cardiopulmonary Bypass : Use of a Novel Modification of the Activated Clotting Time to Monitor Anticoagulation

Heparin-associated Thrombocytopenia and Thrombosis: Implications for Perioperative Management

Practice Guidelines and Treatment of Patients with von Willebrand's Disease

Characterization of Prothrombin Activation during Cardiac Surgery by Hemostatic Molecular Markers

Management of a Patient with Type IIC von Willebrand's Disease during Coronary Artery Bypass Graft Surgery

“Heparin-free” Cardiopulmonary Bypass: First Reported Use of Heparinoid (Org 10172) to Provide Anticoagulation For Cardiopulmonary Bypass

Email alerts

Factor XII Deficiency and Cardiopulmonary Bypass : Use of a Novel Modification of the Activated Clotting Time to Monitor Anticoagulation

Heparin-associated Thrombocytopenia and Thrombosis: Implications for Perioperative Management

Practice Guidelines and Treatment of Patients with von Willebrand's Disease

Characterization of Prothrombin Activation during Cardiac Surgery by Hemostatic Molecular Markers

Management of a Patient with Type IIC von Willebrand's Disease during Coronary Artery Bypass Graft Surgery

“Heparin-free” Cardiopulmonary Bypass: First Reported Use of Heparinoid (Org 10172) to Provide Anticoagulation For Cardiopulmonary Bypass

Email alerts

This Feature Is Available To Subscribers Only